PFBT
ARCT icon

Parkside Financial Bank & Trust’s Arcturus Therapeutics ARCT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538 Buy
+80
New +$631 ﹤0.01% 2582
2025
Q4 		– Sell
-50
Closed -$922 – 2693
2025
Q3 		$922 Hold
50
– – ﹤0.01% 2314
2025
Q2 		$651 Buy
+50
New +$591 ﹤0.01% 2411

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Parkside Financial Bank & Trust's ARCT Position: Q2 2026 in Review

Parkside Financial Bank & Trust opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 80 shares worth $538. The stake represents ﹤0.01% of the portfolio and ranks #2582 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in ARCT as recently as Q3 2025.

Parkside Financial Bank & Trust first reported a position in ARCT in Q2 2025 and has held it in 3 quarters since. The position peaked at $922 in Q3 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Parkside Financial Bank & Trust held 80 shares of Arcturus Therapeutics worth $538 as of Q2 2026.
  • Arcturus Therapeutics was a new Parkside Financial Bank & Trust position in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2582 holding.
  • Parkside Financial Bank & Trust first reported a position in Arcturus Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Parkside Financial Bank & Trust's Arcturus Therapeutics position peaked at $922 in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.